Replies to post #241294 on NorthWest Biotherapeutics Inc (NWBO)

[spartex]

I posted a blurb from WSJ a few months ago saying that he had to dispose of some weak funds from his accounts due to disposition (sales) of clients from some of his biotech funds, as his recent performance was very poor. So he needed to sell shares to raise $$ to cover exiting clients.